In our meta-analysis, DPP4 inhibitors showed an improved effect on cognitive impairment in T2D, and DPP4i has previously been shown to have an improved effect on cognitive impairment [31]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.